IceCure Medical (ICCM) Shares Outstanding (2020 - 2026)

IceCure Medical (ICCM) has 7 years of Shares Outstanding (Entity) data on file, last reported at $2.5 million in Q1 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 27.64% year-over-year to $2.5 million in Q1 2026; TTM through Mar 2026 was $2.5 million, a 27.64% increase from a year earlier, with the FY2025 full-year figure at $2.4 million, up 29.26% from the prior year.
• Shares Outstanding (Entity) for Q1 2026 stood at $2.5 million, up from $2.4 million in the prior quarter.
• Over the last five years, Shares Outstanding (Entity) for ICCM reached as high as $2.5 million in Q1 2026 and fell as low as $1.2 million in Q1 2022.
• Historically, Shares Outstanding (Entity) has averaged $1.7 million across 5 years, with a median of $1.6 million in 2024.
• Across the five-year window, Shares Outstanding (Entity) soared 77.51% in 2022 and grew 2.44% in 2024, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $1.2 million in 2022, then grew by 23.54% to $1.5 million in 2023, then advanced by 23.7% to $1.9 million in 2024, then advanced by 29.26% to $2.4 million in 2025, then advanced by 0.62% to $2.5 million in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $2.5 million in Q1 2026, $2.4 million in Q4 2025, and $2.0 million in Q3 2025.